CARRIE STUBENHOFER: Open Payments
NPI 1710559752 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 32 payments from 14 companies in 2025. Trend: 2023 $1,835 · 2024 $1,727 · 2025 $920
Food & beverage: $920
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 4 | $243 |
| PFIZER INC. | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Medtronic, Inc. | 2 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Recor Medical Inc | 2 | $54 |
| Novo Nordisk Inc | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $30 |
Products named: VYNDAQEL, LEQVIO, LINQ II, JARDIANCE, ELIQUIS, Paradise Ultrasound Renal Denervation System, Wegovy, VERQUVO.
Industry payments across PA — which companies pay providers there.
